DFTX:NASDAQ
Definium Therapeutics Inc
$37.40
arrow_downward
-0.53%(-0.20) 1D
Oct 2, 4:00:01โฏPM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DFTX...
Open
$37.70
High
$38.14
Low
$36.86
Mkt. cap
5.03B
Avg. vol.
2.16M
Volume
149.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.19
Shares outstanding
134.37M
No. of employees
106
Open
$37.70
High
$38.14
Low
$36.86
Mkt. cap
5.03B
Avg. vol.
2.16M
Volume
149.00
52-wk high
$49.70
52-wk low
$14.62
EPS
-$3.43
Beta
2.19
Shares outstanding
134.37M
No. of employees
106
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
·
11 minutes ago
NYSE logo in New York City
WFSB
·
2 hours ago
MORNING BUSINESS REPORT: Busy week ahead on Wall Street, Social Security COLA estimate at 3.7%
Value The Markets
·
3 hours ago
Taylor Devices (NASDAQ: TAYD) Reports Q1 Sales Decline
Yahoo Finance
·
1 hour ago
Should You Invest in the First Trust NASDAQ Bank ETF (FTXO)?
Profile
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
About Definium Therapeutics Inc
CEORobert Barrow
Employees106
Founded2010
Headquarters-
SectorPharmaceutical industry
Websitedefiniumtx.com